Reuters logo
BRIEF-Cerveau Technologies announces FDA acceptance of investigational new drug
June 16, 2017 / 12:42 PM / 3 months ago

BRIEF-Cerveau Technologies announces FDA acceptance of investigational new drug

June 16 (Reuters) - Cerveau Technologies Inc:

* Cerveau Technologies, Inc. announces FDA acceptance of investigational new drug (IND) for Tau Imaging Agent MK-6240

* Cerveau Technologies - MK-6240 is licensed to Cerveau from Merck Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below